Jd Health International Stock Performance
| JDHIY Stock | USD 3.81 0.00 0.00% |
On a scale of 0 to 100, JD Health holds a performance score of 9. The company owns a Beta (Systematic Risk) of -0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning JD Health are expected to decrease at a much lower rate. During the bear market, JD Health is likely to outperform the market. Please check JD Health's market risk adjusted performance, treynor ratio, as well as the relationship between the Treynor Ratio and day typical price , to make a quick decision on whether JD Health's current price history will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in JD Health International are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile forward indicators, JD Health showed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 32.3 B | |
| Total Cashflows From Investing Activities | -17.8 B |
JDHIY |
JD Health Relative Risk vs. Return Landscape
If you would invest 320.00 in JD Health International on September 30, 2024 and sell it today you would earn a total of 61.00 from holding JD Health International or generate 19.06% return on investment over 90 days. JD Health International is currently producing 0.2979% returns and takes up 2.3828% volatility of returns over 90 trading days. Put another way, 21% of traded pink sheets are less volatile than JDHIY, and 95% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
JD Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for JD Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as JD Health International, and traders can use it to determine the average amount a JD Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | JDHIY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.38 actual daily | 21 79% of assets are more volatile |
Expected Return
| 0.3 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average JD Health is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of JD Health by adding it to a well-diversified portfolio.
JD Health Fundamentals Growth
JDHIY Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of JD Health, and JD Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on JDHIY Pink Sheet performance.
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0099 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 29.92 B | |||
| Shares Outstanding | 3.18 B | |||
| Price To Book | 4.59 X | |||
| Price To Sales | 0.84 X | |||
| Revenue | 30.68 B | |||
| EBITDA | (895.49 M) | |||
| Cash And Equivalents | 45.68 B | |||
| Cash Per Share | 14.37 X | |||
| Total Debt | 194.3 M | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 13.33 X | |||
| Cash Flow From Operations | 3.43 B | |||
| Earnings Per Share | (0.05) X | |||
| Total Asset | 48 B | |||
About JD Health Performance
Evaluating JD Health's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if JD Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if JD Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the Peoples Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited. Jd Health is traded on OTC Exchange in the United States.Things to note about JD Health International performance evaluation
Checking the ongoing alerts about JD Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for JD Health International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 30.68 B. Net Loss for the year was (1.07 B) with profit before overhead, payroll, taxes, and interest of 7.2 B. |
- Analyzing JD Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether JD Health's stock is overvalued or undervalued compared to its peers.
- Examining JD Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating JD Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of JD Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of JD Health's pink sheet. These opinions can provide insight into JD Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for JDHIY Pink Sheet Analysis
When running JD Health's price analysis, check to measure JD Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JD Health is operating at the current time. Most of JD Health's value examination focuses on studying past and present price action to predict the probability of JD Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JD Health's price. Additionally, you may evaluate how the addition of JD Health to your portfolios can decrease your overall portfolio volatility.